The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RNAseq analysis of the sorafenib phase III DECISION trial in differentiated thyroid cancer (DTC): Correlation with clinical outcome.
 
Jaume Capdevila
Consulting or Advisory Role - Bayer/Onyx; Ipsen; Sanofi
Research Funding - Bayer (Inst); Onyx (Inst)
 
Ignacio Matos Garcia
No Relationships to Disclose
 
Francesco M Mancuso
No Relationships to Disclose
 
Carmela Iglesias
No Relationships to Disclose
 
Paolo Nuciforo
No Relationships to Disclose
 
Carles Zafon
No Relationships to Disclose
 
Hector G. Palmer
No Relationships to Disclose
 
Zighereda Ogbah
No Relationships to Disclose
 
Laura Muiños
No Relationships to Disclose
 
Carol Elaine Pena
Employment - Bayer/Onyx
Stock and Other Ownership Interests - Bayer/Onyx
Patents, Royalties, Other Intellectual Property - Bayer/Onyx
 
Marcia S. Brose
Honoraria - Bayer; Exelixis; Onyx
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Onyx; Oxigene
Research Funding - Bayer (Inst); Eisai (Inst); Exelixis (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Onyx
 
Martin Schlumberger
Consulting or Advisory Role - Bayer/Onyx; Eisai; Ipsen; Sanofi
 
Ana Vivancos
No Relationships to Disclose